Abstract | OBJECTIVE: DESIGN: Double-arm randomised placebo-controlled trial. SETTING: An outpatient department for vulval disease. POPULATION: METHODS: Twice a week active TENS or sham treatment were delivered through a vaginal probe via a calibrated dual channel YSY-EST device. Women of both groups underwent 20 treatment sessions. MAIN OUTCOME MEASURES: Visual analogue scale (VAS), the short form of the McGill-Melzack Pain Questionnaire (SF-MPQ), the Marinoff Scale for dyspareunia and the Female Sexual Function Index questionnaire (FSFI) were assessed at baseline, at the end of treatment and at follow up 3 months after the end of treatment. RESULTS: The VAS and SF-MPQ scores (6.2 +/- 1.9 and 19.5 +/- 11.9 before treatment, respectively) improved significantly in the active TENS group (2.1 +/- 2.7, P= 0.004 and 8.5 +/- 10.7, P= 0.001, respectively), but not in the placebo group. The Marinoff dyspareunia scale and the FSFI also showed a significant improvement. CONCLUSIONS:
TENS is a simple, effective and safe short-term (3 months) treatment for the management of vestibulodynia.
|
Authors | F Murina, V Bianco, G Radici, R Felice, M Di Martino, U Nicolini |
Journal | BJOG : an international journal of obstetrics and gynaecology
(BJOG)
Vol. 115
Issue 9
Pg. 1165-70
(Aug 2008)
ISSN: 1471-0528 [Electronic] England |
PMID | 18715435
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Topics |
- Adult
- Female
- Humans
- Pain Management
- Pain Measurement
- Surveys and Questionnaires
- Transcutaneous Electric Nerve Stimulation
- Treatment Outcome
- Vulvar Vestibulitis
(therapy)
|